Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Severe hypoglycemia reduces the shivering threshold in rabbits.

Wada K, Masamune T, Ino H, Ueda K, Ishiyama T, Sessler DI, Matsukawa T.

BMC Anesthesiol. 2019 Jul 9;19(1):126. doi: 10.1186/s12871-019-0794-7.

2.

Analgesic effects of amiodarone in mouse models of pain.

Kotoda M, Ino H, Kumakura Y, Iijima T, Ishiyama T, Matsukawa T.

J Pain Res. 2019 Jun 6;12:1825-1832. doi: 10.2147/JPR.S196480. eCollection 2019.

3.

Incidence of Thyroid Cancer Among Children and Young Adults in Fukushima, Japan.

Akabayashi A, Nakazawa E, Ino H.

JAMA Otolaryngol Head Neck Surg. 2019 Jun 13. doi: 10.1001/jamaoto.2019.1105. [Epub ahead of print] No abstract available.

PMID:
31194245
4.

Effects on postgraduate-year-I residents of simulation-based learning compared to traditional lecture-style education led by postgraduate-year-II residents: a pilot study.

Yamamoto A, Obika M, Mandai Y, Murakami T, Miyoshi T, Ino H, Kataoka H, Otsuka F.

BMC Med Educ. 2019 Mar 20;19(1):87. doi: 10.1186/s12909-019-1509-y.

5.

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects.

Ino H, Doi Y, Liefaard L, Cookson L, Chen C, Itoh H, Igarashi H, Nakano A.

Clin Pharmacol Drug Dev. 2019 Jul;8(5):612-618. doi: 10.1002/cpdd.631. Epub 2018 Dec 17.

PMID:
30556959
6.

Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects.

Ino H, Wilson R, Terao T, Ogura H, Igarashi H, Cahn A, Numachi Y.

Clin Pharmacol Drug Dev. 2019 Jan;8(1):78-86. doi: 10.1002/cpdd.614. Epub 2018 Oct 10.

PMID:
30303626
7.

Limited effects of long-term enzyme replacement therapy on the cardiac conduction system in Fabry disease.

Kaneda T, Takeda M, Suematsu T, Yamamoto R, Takata M, Higashikata T, Ino H, Tsujibata A, Hayashi K, Fujino N, Kawashiri MA.

J Cardiol Cases. 2018 Feb 9;17(5):178-181. doi: 10.1016/j.jccase.2018.01.004. eCollection 2018 May.

8.

Low Baseline High-Sensitive C-Reactive Protein is Associated with Coronary Atherosclerosis Regression: Insights from the MILLION Study.

Sakata K, Gamou T, Tada H, Hayashi K, Ino H, Yamagishi M; Masa-aki Kawashiri; behalf of the MILLION Study Group.

J Atheroscler Thromb. 2019 May 1;26(5):442-451. doi: 10.5551/jat.44255. Epub 2018 Sep 21.

9.

Sacrificing the Fukushima 50 again?

Akabayashi A, Nakazawa E, Ino H, Ozeki-Hayashi R, Jecker NS.

J Public Health (Oxf). 2018 Aug 28. doi: 10.1093/pubmed/fdy143. [Epub ahead of print]

PMID:
30165403
10.

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers.

Ino H, Endo A, Wakamatsu A, Ogura H, Numachi Y, Kendrick S.

Clin Pharmacol Drug Dev. 2019 Jan;8(1):70-77. doi: 10.1002/cpdd.576. Epub 2018 Jun 5.

PMID:
29870578
11.

Evaluation of Bioequivalence Between 0.5-mg Dutasteride Capsules Manufactured by GlaxoSmithKline and an Existing Formulation: A Randomized Study in Healthy Japanese Male Volunteers.

Ino H, Itoh H, Doi Y, Igarashi H, Numachi Y.

Clin Pharmacol Drug Dev. 2018 Mar;7(3):341-346. doi: 10.1002/cpdd.407. Epub 2017 Dec 28. No abstract available.

PMID:
29283507
12.

Overview of the 81st Annual Scientific Meeting of the Japanese Circulation Society - Cardiovascular Medicine for the Next Generation.

Fujino N, Yoshimuta T, Ichida F, Kinugawa K, Usuda K, Kitayama M, Ino H, Kawashiri MA, Tada H, Mizuno S, Hayashi K, Takemura H, Yamagishi M; all the members of the Japanese Circulation Society in Hokuriku District.

Circ J. 2017 Aug 25;81(9):1261-1267. doi: 10.1253/circj.CJ-17-0706. Epub 2017 Aug 8.

13.

Effect of Reverse Vessel Remodeling on Regression of Coronary Atherosclerosis in Patients Treated With Aggressive Lipid- and Blood Pressure-Lowering Therapy - Insight From MILLION Study.

Gamou T, Sakata K, Tada H, Konno T, Hayashi K, Ino H, Yamagishi M, Kawashiri MA; MILLION Study Group.

Circ J. 2017 Sep 25;81(10):1490-1495. doi: 10.1253/circj.CJ-16-1253. Epub 2017 May 17.

14.

Acute necrotizing eosinophilic myocarditis complicated by complete atrioventricular block promptly responded to glucocorticoid therapy.

Kaneda T, Iwai S, Suematsu T, Yamamoto R, Takata M, Higashikata T, Ino H, Tsujibata A.

J Cardiol Cases. 2017 Apr 14;16(1):5-8. doi: 10.1016/j.jccase.2017.03.002. eCollection 2017 Jul.

15.

Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study.

Kawashiri MA, Sakata K, Hayashi K, Gamou T, Kanaya H, Miwa K, Ueda K, Higashikata T, Mizuno S, Michishita I, Namura M, Nitta Y, Katsuda S, Okeie K, Hirase H, Tada H, Uchiyama K, Konno T, Ino H, Nagase K, Yamagishi M; Behalf of the MILLION Study Group.

Heart Vessels. 2017 May;32(5):539-548. doi: 10.1007/s00380-016-0910-2. Epub 2016 Oct 31.

PMID:
27798731
16.

Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.

Kimura H, Kanahara N, Sasaki T, Komatsu N, Ishige M, Muneoka K, Ino H, Yoshimura K, Yamanaka H, Suzuki T, Komatsu H, Watanabe H, Shimizu E, Iyo M.

J Psychopharmacol. 2016 Aug;30(8):795-802. doi: 10.1177/0269881116655978. Epub 2016 Jul 1.

PMID:
27371496
17.

Impact of Updated Diagnostic Criteria for Long QT Syndrome on Clinical Detection of Diseased Patients: Results From a Study of Patients Carrying Gene Mutations.

Hayashi K, Konno T, Fujino N, Itoh H, Fujii Y, Imi-Hashida Y, Tada H, Tsuda T, Tanaka Y, Saito T, Ino H, Kawashiri MA, Ohta K, Horie M, Yamagishi M.

JACC Clin Electrophysiol. 2016 Jun;2(3):279-287. doi: 10.1016/j.jacep.2016.01.003. Epub 2016 Mar 23.

18.

Unusual Case of Cardiac Amyloidosis Preceded by a Twenty-year History of Dilated Cardiomyopathy and Heart Failure.

Shimada S, Maekura S, Ino H, Matsuura M, Masunaga N, Matsumoto T, Hama J.

Intern Med. 2016;55(9):1109-15. doi: 10.2169/internalmedicine.55.5835. Epub 2016 May 1.

19.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of losmapimod in healthy Japanese volunteers.

Ino H, Takahashi N, Terao T, Igarashi H, Sarai N.

Clin Pharmacol Drug Dev. 2015 Jul;4(4):262-9. doi: 10.1002/cpdd.190. Epub 2015 May 7.

PMID:
27136906
20.

Topic: Inguinal Hernia - Unsolved problem in the daily practice.

Yasuo S, Kenichi Y, Ueno N, Arimoto A, Hosono M, Yoshikawa T, Toyokawa A, Kakeji Y, Tsai Y, Tsai C, Sul J, Lim M, Park J, Jang CE, Santilli O, Tripoloni D, Santilli H, Nardelli N, Greco A, Estevez M, Sakurai S, Ryu S, Cesana G, Ciccarese F, Uccelli M, Grava G, Castello G, Carrieri D, Legnani G, Olmi S, Naito M, Yamamoto H, Sawada Y, Mandai Y, Asano H, Ino H, Tsukuda K, Nagahama T, Ando M, Ami K, Arai K, Miladinovic M, Kitanovic A, Lechner M, Mayer F, Meissnitzer M, Fortsner R, Öfner D, Köhler G, Jäger T, Kumata Y, Fukushima R, Inaba T, Yaguchi Y, Horikawa M, Ogawa E, Katayama T, Kumar PS, Unal D, Caparlar C, Akkaya T, Mercan U, Kulacoglu H, Barreiro JJ, Baer IG, García LS, Cumplido PL, Florez LJ, Muñiz PF, Fujino K, Mita K, Ohta E, Takahashi K, Hashimoto M, Nagayasu K, Murabayashi R, Asakawa H, Koizumi K, Hayashi G, Ito H, Felberbauer F, Strobl S, Kristo I, Riss S, Prager G, El Komy H, El Gendi A, Nabil W, Karam M, El Kayal S, Chihara N, Suzuki H, Watanabe M, Uchida E, Chen T, Wang J, Wang H, Bouchiba N, Elbakary T, Ramadan A, Elakkad M, Berney C, Vlasov V, Babii I, Pidmurnyak O, Prystupa M, Asakage N, Molinari P, Contino E, Guzzetti L, Oggioni M, Sambuco M, Berselli M, Farassino L, Cocozza E, Crespi A, Ambrosoli A, Zhao Y.

Hernia. 2015 Apr;19 Suppl 1:S293-304. doi: 10.1007/BF03355374. No abstract available.

PMID:
26518826
21.

Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.

Nomura A, Tada H, Teramoto R, Konno T, Hodatsu A, Won HH, Kathiresan S, Ino H, Fujino N, Yamagishi M, Hayashi K.

J Cardiol. 2016 Feb;67(2):133-9. doi: 10.1016/j.jjcc.2015.09.003. Epub 2015 Oct 9.

22.

Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation.

Hayashi K, Konno T, Tada H, Tani S, Liu L, Fujino N, Nohara A, Hodatsu A, Tsuda T, Tanaka Y, Kawashiri MA, Ino H, Makita N, Yamagishi M.

Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1095-104. doi: 10.1161/CIRCEP.114.002519. Epub 2015 Jun 30.

PMID:
26129877
23.

The Effects of Blood Glucose Concentration on the Shivering Threshold in Rabbits.

Ino H, Masamune T, Sato H, Okuyama K, Wada K, Iwashita H, Ishiyama T, Oguchi T, Sessler DI, Matsukawa T.

Anesth Analg. 2015 Aug;121(2):525-31. doi: 10.1213/ANE.0000000000000844.

PMID:
26086618
24.

Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers.

Fossler MJ, Collins DA, Ino H, Sarai N, Ravindranath R, Bowen CL, Burns O.

J Drug Assess. 2015 Jul 14;4(1):24-9. doi: 10.3109/21556660.2015.1067219. eCollection 2015.

25.

Systemic exposure to benzoic acid and hippuric acid following topical application of clindamycin 1%/benzoyl peroxide 3% fixed-dose combination gel in Japanese patients with acne vulgaris.

Ino H, Takahashi N, Saenz AA, Wakamatsu A, Hashimoto H, Nakahara N, Hasegawa S.

Clin Pharmacol Drug Dev. 2015 Jan;4(1):18-24. doi: 10.1002/cpdd.125. Epub 2014 Jun 9.

PMID:
27128000
26.

Impact of combined lipid lowering with blood pressure control on coronary plaque regression: rationale and design of MILLION study.

Kawashiri MA, Sakata K, Gamou T, Kanaya H, Miwa K, Ueda K, Higashikata T, Mizuno S, Michishita I, Namura M, Nitta Y, Katsuda S, Okeie K, Hirase H, Tada H, Uchiyama K, Konno T, Hayashi K, Ino H, Nagase K, Terashima M, Yamagishi M.

Heart Vessels. 2015 Sep;30(5):580-6. doi: 10.1007/s00380-014-0522-7. Epub 2014 Jun 4.

PMID:
24895097
27.

Sarcomere gene mutations are associated with increased cardiovascular events in left ventricular hypertrophy: results from multicenter registration in Japan.

Fujita T, Fujino N, Anan R, Tei C, Kubo T, Doi Y, Kinugawa S, Tsutsui H, Kobayashi S, Yano M, Asakura M, Kitakaze M, Komuro I, Konno T, Hayashi K, Kawashiri MA, Ino H, Yamagishi M.

JACC Heart Fail. 2013 Dec;1(6):459-66. doi: 10.1016/j.jchf.2013.08.007. Epub 2013 Oct 24.

28.

Comparison of levocetirizine pharmacokinetics after single doses of levocetirizine oral solution and cetirizine dry syrup in healthy Japanese male subjects.

Ino H, Hara K, Honma G, Doi Y, Fukase H.

J Drug Assess. 2014 Jun 3;3(1):38-42. doi: 10.3109/21556660.2014.928302. eCollection 2014.

29.

Impact of lesion morphology and associated procedures for left main coronary stenting on angiographic outcome after intervention: sub-analysis of Heart Research Group of Kanazawa, HERZ, Study.

Kawashiri MA, Sakata K, Uchiyama K, Konno T, Namura M, Mizuno S, Tatami R, Kanaya H, Nitta Y, Michishita I, Hirase H, Ueda K, Aoyama T, Okeie K, Haraki T, Mori K, Araki T, Minamoto M, Oiwake H, Ino H, Hayashi K, Yamagishi M.

Cardiovasc Interv Ther. 2014 Apr;29(2):117-22. doi: 10.1007/s12928-013-0222-8. Epub 2013 Nov 8.

PMID:
24203580
30.

The pharmacokinetics and safety profiles of belimumab after single subcutaneous and intravenous doses in healthy Japanese volunteers.

Shida Y, Takahashi N, Sakamoto T, Ino H, Endo A, Hirama T.

J Clin Pharm Ther. 2014 Feb;39(1):97-101. doi: 10.1111/jcpt.12101. Epub 2013 Oct 5.

PMID:
24117862
31.

Single-Dose Pharmacokinetics of the CCR9 Receptor Antagonist Vercirnon in Healthy US and Japanese Subjects.

Haberer LJ, Hacquoil K, Ino H, Sakamoto T, Kanemoto N, McSherry I, Hirama T.

Clin Pharmacol Drug Dev. 2013 Oct;2(4):387-93. doi: 10.1002/cpdd.41. Epub 2013 Aug 11.

PMID:
27121943
32.

Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.

Kawashiri MA, Hayashi K, Konno T, Fujino N, Ino H, Yamagishi M.

Heart Vessels. 2014 Mar;29(2):129-41. doi: 10.1007/s00380-013-0391-5. Epub 2013 Aug 2. Review.

PMID:
23907713
33.

Is exercise-related QT interval shortening with a peaked T wave a specific electrocardiographic finding of pheochromocytoma?

Hayashi K, Konno T, Ino H, Yamagishi M.

J Cardiol Cases. 2013 Mar 7;7(4):e117-e118. doi: 10.1016/j.jccase.2013.01.007. eCollection 2013 Apr. No abstract available.

34.

Pharmacokinetics, safety, and tolerability following single-dose migalastat hydrochloride (GR181413A/AT1001) in healthy male Japanese subjects.

Ino H, Takahashi N, Terao T, Mudd PN Jr, Hirama T.

J Drug Assess. 2013 Jul 24;2(1):87-93. doi: 10.3109/21556660.2013.827117. eCollection 2013.

35.

Identification of a Bioactive Compound against Adult T-cell Leukaemia from Bitter Gourd Seeds.

Kai H, Akamatsu E, Torii E, Kodama H, Yukizaki C, Akagi I, Ino H, Sakakibara Y, Suiko M, Yamamoto I, Okayama A, Morishita K, Kataoka H, Matsuno K.

Plants (Basel). 2013 Dec 27;3(1):18-26. doi: 10.3390/plants3010018.

36.

Impact of systolic dysfunction in genotyped hypertrophic cardiomyopathy.

Fujino N, Konno T, Hayashi K, Hodatsu A, Fujita T, Tsuda T, Nagata Y, Kawashiri MA, Ino H, Yamagishi M.

Clin Cardiol. 2013 Mar;36(3):160-5. doi: 10.1002/clc.22082. Epub 2012 Nov 29.

37.

[Efficacy and toxicity of lapatinib plus capecitabine therapy in HER2-positive metastatic breast cancer].

Chiba A, Shimizu S, Yoshida A, Inaba M, Matsuura H, Ino H, Suganuma N, Inari H, Yamanaka T, Kuroda K, Mukaibashi T, Matsuo A, Kojima I.

Gan To Kagaku Ryoho. 2012 Nov;39(11):1675-9. Japanese.

PMID:
23152018
38.

A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome.

Liu L, Hayashi K, Kaneda T, Ino H, Fujino N, Uchiyama K, Konno T, Tsuda T, Kawashiri MA, Ueda K, Higashikata T, Shuai W, Kupershmidt S, Higashida H, Yamagishi M.

Heart Rhythm. 2013 Jan;10(1):61-7. doi: 10.1016/j.hrthm.2012.09.053. Epub 2012 Sep 23.

PMID:
23010577
39.

Non-bacterial thrombotic endocarditis associated with Trousseau's syndrome.

Nakashima K, Mori M, Haraki T, Hirase H, Yoshimuta T, Ichida F, Okeie K, Konno T, Hayashi K, Ino H, Kawashiri MA, Yamagishi M.

J Echocardiogr. 2012 Sep;10(3):115-6. doi: 10.1007/s12574-012-0125-1. Epub 2012 Jun 8. No abstract available.

PMID:
27278214
40.

[Aplastic anemia complicated with ulcerative colitis].

Shimada T, Maeda T, Ishikawa M, Okamura D, Ito Y, Wakimoto N, Nakamura Y, Kawai N, Ino H, Jinnai I, Mori S, Matsuda A, Bessho M.

Rinsho Ketsueki. 2012 Feb;53(2):224-8. Japanese.

PMID:
22450583
41.

The effects of moderate-intensity gradient static magnetic fields on nerve conduction.

Okano H, Ino H, Osawa Y, Osuga T, Tatsuoka H.

Bioelectromagnetics. 2012 Sep;33(6):518-26. doi: 10.1002/bem.21717. Epub 2012 Mar 16.

PMID:
22430817
42.

Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer.

Nakamura S, Ando M, Masuda N, Aogi K, Ino H, Iwata H, Tokuda Y, Yamamoto N, Kasai H, Takeuchi M, Tsuda H, Akiyama F, Kurosumi M, Fujiwara Y.

Clin Breast Cancer. 2012 Feb;12(1):49-56. doi: 10.1016/j.clbc.2011.10.002. Epub 2011 Dec 6.

PMID:
22154118
43.

Cardiac papillary fibroelastoma originated from atrial side of mitral valve leaflet.

Mori M, Kawashiri MA, Hayashi T, Konno T, Hayashi K, Ino H, Yoshimuta T, Okeie K, Ichida F, Tomita S, Watanabe G, Yamagishi M.

J Echocardiogr. 2011 Dec;9(4):156-7. doi: 10.1007/s12574-011-0092-y. Epub 2011 May 24. No abstract available.

PMID:
27277296
44.

Impact of endoscopic and histological evaluations of two different types of mesh plug for a groin hernia model.

Mandai Y, Naito M, Hayashi T, Asano H, Ino H, Tsukuda K, Miyoshi S.

Surg Today. 2011 Nov;41(11):1512-8. doi: 10.1007/s00595-010-4520-9. Epub 2011 Oct 4.

PMID:
21969154
45.

Ureido-derivatized polymers based on both poly(allylurea) and poly(L-citrulline) exhibit UCST-type phase transition behavior under physiologically relevant conditions.

Shimada N, Ino H, Maie K, Nakayama M, Kano A, Maruyama A.

Biomacromolecules. 2011 Oct 10;12(10):3418-22. doi: 10.1021/bm2010752. Epub 2011 Sep 21.

PMID:
21928793
46.

Intravascular ultrasound appearance of scattered necrotic core as an index for deterioration of coronary flow during intervention in acute coronary syndrome.

Sakata K, Kawashiri MA, Ino H, Matsubara T, Uno Y, Yasuda T, Miwa K, Kanaya H, Yamagishi M.

Heart Vessels. 2012 Sep;27(5):443-52. doi: 10.1007/s00380-011-0175-8. Epub 2011 Aug 12.

PMID:
21837498
47.

Impact of bilateral internal thoracic-to-epigastric artery communications on salvaging total lower limb ischemia.

Tada H, Tsubokawa T, Konno T, Hayashi K, Uchiyama K, Kawashiri MA, Tomita S, Ino H, Watanabe G, Yamagishi M.

J Am Coll Cardiol. 2011 Aug 2;58(6):654. doi: 10.1016/j.jacc.2010.10.073. No abstract available.

48.

Impact of severe coronary disease associated or not associated with diabetes mellitus on outcome of interventional treatment using stents: results from HERZ (Heart Research Group of Kanazawa) analyses.

Uchiyama K, Ino H, Hayashi K, Fujioka K, Takabatake S, Yokawa J, Namura M, Mizuno S, Tatami R, Kanaya H, Nitta Y, Michishita I, Hirase H, Ueda K, Aoyama T, Okeie K, Haraki T, Mori K, Araki T, Minamoto M, Oiwake H, Konno T, Sakata K, Kawashiri M, Yamagishi M; Heart Research Group of Kanazawa.

J Int Med Res. 2011;39(2):549-57.

PMID:
21672360
49.

Rapid progression of coronary artery disease in a patient with retroperitoneal fibrosis.

Oe K, Araki T, Konno T, Sakata K, Hayashi K, Ino H, Yamagishi M.

J Cardiol Cases. 2011 May 25;4(1):e20-e25. doi: 10.1016/j.jccase.2011.05.001. eCollection 2011 Aug.

50.

Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues.

Demura M, Wang F, Yoneda T, Karashima S, Mori S, Oe M, Kometani M, Sawamura T, Cheng Y, Maeda Y, Namiki M, Ino H, Fujino N, Uchiyama K, Tsubokawa T, Yamagishi M, Nakamura Y, Ono K, Sasano H, Demura Y, Takeda Y.

J Hypertens. 2011 Jun;29(6):1185-95. doi: 10.1097/HJH.0b013e32834626bb.

PMID:
21546879

Supplemental Content

Support Center